Rhabdovirus evasion of the interferon system

Journal of Interferon and Cytokine Research

Volumn 29, Issue 9, 2009, Pages 499-509

  Rieder, Martina ^a   Conzelmann, Karl Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERFERON; MATRIX PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; STAT PROTEIN; TOLL LIKE RECEPTOR; VIRUS PROTEIN; VIRUS RNA;

CYTOPATHOGENIC EFFECT; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RABIES VIRUS; REVIEW; RHABDOVIRUS; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS GENOME; VIRUS INTERFERENCE; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS TRANSMISSION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; INTERFERONS; RHABDOVIRIDAE; RHABDOVIRIDAE INFECTIONS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; VIRULENCE; VIRUS REPLICATION;

HEXAPODA; MAMMALIA; PARAMYXOVIRIDAE; RABIES VIRUS; RHABDOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 70349243493     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0068     Document Type: Review

References (121)

1. Abraham G, Banerjee AK. 1976. Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci USA 73:1504-1508.
2. Ahmed M, Brzoza KL, Hiltbold EM. 2006. Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J Virol 80:2194-2205. (Pubitemid 43271526)
3. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77:4646-4657. (Pubitemid 36402814)
4. Akira S, Takeda K. 2004. Functions of toll-like receptors: lessons from KO mice. C R Biol 327:581-589. (Pubitemid 38979508)
5. Albertini AA, Schoehn G, Weissenhorn W, Ruigrok RW. 2008. Structural aspects of rabies virus replication. Cell Mol Life Sci 65:282-294. (Pubitemid 351161483)
6. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264-17269. (Pubitemid 39627808)
7. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, Barber GN 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141. (Pubitemid 30953958)
8. Balachandran S, Thomas E, Barber GN. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401-405. (Pubitemid 39551675)
9. Banerjee AK. 2008. Response to Non-segmented negative-strand RNA virus RNA synthesis in vivo. Virology 371:231-233.
10. Barchet W, Cella M, Odermatt B, Asselin-Paturel C, Colonna M, Kalinke U. 2002. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 195:507-516. (Pubitemid 34461303)
11. Basak S, Mondal A, Polley S, Mukhopadhyay S, Chattopadhyay D. 2007. Reviewing Chandipura: a vesiculovirus in human epidemics. Biosci Rep 27:275-298. (Pubitemid 47222904)
12. Black BL, Lyles DS. 1992. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66:4058-4064.
13. Black BL, Rhodes RB, McKenzie M, Lyles DS. 1993. The role of vesicular stomatitis virus matrix protein in inhibition of hostdirected gene expression is genetically separable from its function in virus assembly. J Virol 67:4814-4821. (Pubitemid 23215962)
14. Blondel D, Harmison GG, Schubert M. 1990. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64:1716-1725. (Pubitemid 20104910)
15. Blondel D, Regad T, Poisson N, Pavie B, Harper F, Pandolfi PP, De The H, Chelbi-Alix MK. 2002. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21:7957-7970. (Pubitemid 35430607)
16. Both GW, Banerjee AK, Shatkin AJ. 1975. Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci USA 72:1189-1193.
17. Bowzard JB, Ranjan P, Sambhara S, Fujita T. 2009. Antiviral defense: RIG-Ing the immune system to STING. Cytokine Growth Factor Rev 20:1-5.
18. Brzozka K, Finke S, Conzelmann KK. 2005. Identifi cation of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79:7673-7681. (Pubitemid 40756801)
19. Brzozka K, Finke S, Conzelmann KK. 2006. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80:2675-2683. (Pubitemid 43346363)
20. Brzozka K, Pfaller C, Conzelmann KK. 2007. Signal transduction in the type I interferon system and viral countermeasures. Signal Transduction 7:5-19. (Pubitemid 46326740)
21. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, De The H. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72:1043-1051. (Pubitemid 28116883)
22. Chen ZJ. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758-765.
23. Chenik M, Chebli K, Blondel D. 1995. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J Virol 69:707-712.
24. Colonno RJ, Banerjee AK. 1976. A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell 8:197-204.
25. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, Fujita T, Conzelmann KK, Krug A, Hopfner KP. 2008. The C-terminal regulatory domain is the RNA 5-triphosphate sensor of RIG-I. Mol Cell 29:169-179. (Pubitemid 351172822)
26. Curran J, Kolakofsky D. 2008. Nonsegmented negative-strand RNA virus RNA synthesis in vivo. Virology 371:227-230.
27. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB. 2004. Does Toll-like receptor 3 play a biological role in virus infections Virology 322:231-238.
28. Enninga J, Levy DE, Blobel G, Fontoura BM. 2002. Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295:1523-1525. (Pubitemid 34174007)
29. Eriguchi Y, Toriumi H, Kawai A. 2002. Studies on the rabies virus RNA polymerase: 3. Two-dimensional electrophoretic analysis of the multiplicity of non-catalytic subunit (P protein). Microbiol Immunol 46:463-474.
30. Everett RD, Chelbi-Alix MK. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819-830.
31. Faria PA, Chakraborty P, Levay A, Barber GN, Ezelle HJ, Enninga J, Arana C, van Deursen J, Fontoura BM. 2005. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell 17:93-102. (Pubitemid 40075368)
32. Ferran MC, Lucas-Lenard JM. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71;371-377.
33. Field AK, Tytell AA, Lampson GP, Hilleman MR. 1967. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci USA 58:1004-1010.
34. Finke S, Brzozka K, Conzelmann KK. 2004. Tracking fl uorescencelabeled rabies virus: enhanced green fl uorescent protein-tagged phosphoprotein P supports virus gene expression and formation of infectious particles. J Virol 78:12333-12343. (Pubitemid 39458752)
35. Finke S, Conzelmann KK. 2005. Replication strategies of rabies virus. Virus Res 111:120-131.
36. Finke S, Cox JH, Conzelmann KK. 2000. Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene. J Virol 74:7261-7269. (Pubitemid 30613073)
37. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198:1043-1055. (Pubitemid 37248620)
38. Fu ZF. 2005. Genetic comparison of the rhabdoviruses from animals and plants. Curr Top Microbiol Immunol 292:1-24. (Pubitemid 40593528)
39. Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, Nakanishi M. 2003. Identifi cation of NAP1, a regulatory subunit of IkappaB kinaserelated kinases that potentiates NF-kappaB signaling. Mol Cell Biol 23:7780-7793. (Pubitemid 37271475)
40. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-fi nger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. (Pubitemid 46633167)
41. Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, Hoebe K, Bahram S, Oldstone MB, Beutler B. 2007. Vesicular stomatitis virus glycoprotein G activates a specifi c antiviral Toll-like receptor 4-dependent pathway. Virology 362:304-313. (Pubitemid 46678142)
42. Gitlin L, Barchet W, Gilfi llan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459-8464.
43. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Hacker G, Mann M, Karin M. 2006. Specifi city in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207. (Pubitemid 43083141)
44. Haller O, Kochs G, Weber F. 2007a. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 18:425-433.
45. Haller O, Staeheli P, Kochs G. 2007b. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812-818. (Pubitemid 47001645) (Pubitemid 47001645)
46. Honda K, Taniguchi T. 2006. IRFs: master regulators of signaling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6;644-658. (Pubitemid 44298214)
47. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. 2004. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101:15416-15421. (Pubitemid 39441556)
48. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
49. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of tolllike receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537. (Pubitemid 34441357)
50. Huang AS, Wagner RR. 1965. Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci USA 54:1579-1584.
51. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20:197-216.
52. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specifi c involvement of RIG-I in antiviral response. Immunity 23;19-28. (Pubitemid 41019654)
53. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
54. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S. 2004. Interferon-alpha induction through Toll-like receptors involves
55. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-Iand Mda5-mediated type I interferon induction 63. Nat Immunol 6:981-988. (Pubitemid 41486182)
56. Kerr IM, Brown RE, Ball LA. 1974. Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature 250:57-59.
57. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203:1795-1803. (Pubitemid 44036284)
58. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401.
59. Lafon M. 2005. Modulation of the immune response in the nervous system by rabies virus. Curr Top Microbiol Immunol 289:239-258. (Pubitemid 40283466)
60. Lazzarini RA, Keene JD, Schubert M. 1981. The origins of defective interfering particles of the negative-strand RNA viruses. Cell 26:145-154. (Pubitemid 12244494)
61. Lebleu B, Sen GC, Shaila S, Cabrer B, Lengyel P. 1976. Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci USA 73:3107-3111.
62. Lee SB, Bablanian R, Esteban M. 1996. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J Interferon Cytokine Res 16:1073-1078. (Pubitemid 26427041)
63. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398-1401. (Pubitemid 46399546)
64. Leroy M, Pire G, Baise E, Desmecht D. 2006. Expression of the interferon- alpha/beta-inducible bovine Mx1 dynamin interferes with replication of rabies virus. Neurobiol Dis 21:515-521. (Pubitemid 43277534)
65. Li J, Wang JT, Whelan SP. 2006. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci USA 103:8493-8498. (Pubitemid 43838483)
66. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez- Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335-345.
67. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101:5598-5603. (Pubitemid 38481202)
68. Luo M, Green TJ, Zhang X, Tsao J, Qiu S. 2007a. Conserved characteristics of the rhabdovirus nucleoprotein. Virus Res 129:246-251.
69. Luo M, Green TJ, Zhang X, Tsao J, Qiu S. 2007b. Structural comparisons of the nucleoprotein from three negative strand RNA virus families. Virol J 4:72. Marcus PI, Sekellick MJ. 1977. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 266:815-819. (Pubitemid 47593578)
70. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. (Pubitemid 41509355)
71. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J. 2008. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28:651-661.
72. Munoz-Fontela C, Garcia MA, Collado M, Marcos-Villar L, Gallego P, Esteban M, Rivas C. 2007. Control of virus infection by tumour suppressors. Carcinogenesis 28:1140-1144. (Pubitemid 47062671)
73. Naeve CW, Kolakofsky CM, Summers DF. 1980. Comparison of vesicular stomatitis virus intracellular and virion ribonucleoproteins. J Virol 33:856-865. (Pubitemid 10176548)
74. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Tolllike receptor-dependent and -independent antiviral response. Nature 439:208-211. (Pubitemid 43083142)
75. Ogino T, Banerjee AK. 2007. Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell 25:85-97. (Pubitemid 46049056)
76. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282:7576-7581. (Pubitemid 47093699)
77. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4:161-167. (Pubitemid 36193018)
78. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. 2009. Riplet/ RNF135, a RING fi nger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284:807-817.
79. Pasdeloup D, Poisson N, Raux H, Gaudin Y, Ruigrok RW, Blondel D. 2005. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 334:284-293. (Pubitemid 40386962)
80. Perrault J. 1981. Origin and replication of defective interfering particles. Curr Top Microbiol. Immunol 93:151-207.
81. Petersen JM, Her LS, Varvel V, Lund E, Dahlberg JE. 2000. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20:8590-8601. (Pubitemid 30805194)
82. Pfaller CK, Conzelmann KK. 2008. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 82:12365-12373.
83. Pichlmair A, Reis e Sousa C. 2007. Innate recognition of viruses. Immunity 27:370-383.
84. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to single- stranded RNA bearing 5-phosphates. Science 314:997-1001.
85. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 5:375-386.
86. Pomerantz JL, Baltimore D. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKKrelated kinase. EMBO J 18:6694-6704.
87. Prestwich RJ, Harrington KJ, Pandha HS, Vile RG, Melcher AA, Errington F. 2008. Oncolytic viruses: a novel form of immunotherapy. Expert Rev Anticancer Ther 8:1581-1588.
88. Publicover J, Ramsburg E, Robek M, Rose JK. 2006. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. J Virol 80:7028-7036. (Pubitemid 44025201)
89. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1-47.
90. Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, Schoenemeyer A, Yamamoto M, Akira S, Fitzgerald KA. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175:5260-5268. (Pubitemid 41456411)
91. Ryzhakov G, Randow F. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26:3180-3190. (Pubitemid 47057483)
92. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 104:582-587. (Pubitemid 46123068)
93. Sandrock M, Frese M, Haller O, Kochs G. 2001. Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. J Interferon Cytokine Res 21:663-668. (Pubitemid 32955696)
94. Sasai M, Oshiumi H, Matsumoto M, Inoue N, Fujita F, Nakanishi M, Seya T. 2005. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domaincontaining adapter molecule-1-mediated IFN regulatory factor 3 activation. J Immunol 174:27-30. (Pubitemid 40007387)
95. Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 177:8676-8683. (Pubitemid 44893832)
96. Schabbauer G, Luyendyk J, Crozat K, Jiang Z, Mackman N, Bahram S, Georgel P. 2008. TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages. Mol Immunol 45:2790-2796.
97. Sekellick MJ, Marcus PI. 1982. Interferon induction by viruses. VIII. Vesicular stomatitis virus: [+/-]DI-011 particles induce interferon in the absence of standard virions. Virology 117:280-285.
98. Sen GC, Peters GA. 2007. Viral stress-inducible genes. Adv Virus Res 70:233-263.
99. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identifi cation and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
100. Silverman RH. 2007. Viral encounters with 2,5-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81:12720-12729. (Pubitemid 350156909)
101. Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, Lichty BD, Brown EG, Sonenberg N, Bell JC. 2000. The murine doublestranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74:9580-9585. (Pubitemid 30746808)
102. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351:101-111. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ. 2006. The specifi c and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642. (Pubitemid 44037666)
103. Uematsu S, Akira S. 2007. Toll-like receptors and Type I interferons. J Biol Chem 282:15319-15323.
104. Venkataraman T, Valdes M, Elsby R, Kakuta S, Caceres G, Saijo S, Iwakura Y, Barber GN. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 178:6444-6455. (Pubitemid 46717428)
105. Vidy A, Chelbi-Alix M, Blondel D. 2005. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79:14411 14420. (Pubitemid 41552738)
106. Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D. 2007. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81:4255-4263. (Pubitemid 46586919)
107. von Kobbe C, van Deursen JM, Rodrigues JP, Sitterlin D, Bachi A, Wu X, Wilm M, Carmo-Fonseca M, Izaurralde E. 2000. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell 6: 1243-1252.
108. Wertz GW, Youngner JS. 1970. Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus. J Virol 6:476-484.
109. Whelan SP. 2008. Response to Non-segmented negative-strand RNA virus RNA synthesis in vivo. Virology 371:234-237.
110. Whelan SP, Barr JN, Wertz GW. 2004. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61-119. (Pubitemid 38667558)
111. Wickersham IR, Finke S, Conzelmann KK, Callaway EM. 2007a. Retrograde neuronal tracing with a deletion-mutant rabies virus. Nat Methods 4:47-49. (Pubitemid 46029475)
112. Wickersham IR, Lyon DC, Barnard RJ, Mori T, Finke S, Conzelmann KK, Young JA, Callaway EM. 2007b. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 53:639-647. (Pubitemid 46283372)
113. Williams BR. 1999. PKR; a sentinel kinase for cellular stress. Oncogene 18:6112-6120.
114. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740. (Pubitemid 41316668)
115. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003a. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643. (Pubitemid 36927946) (Pubitemid 36927946)
116. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S. 2003b. TRAM is specifi - cally involved in the Toll-like receptor 4-mediated MyD88- independent signaling pathway. Nat Immunol 4:1144-1150. (Pubitemid 37428043) (Pubitemid 37428043)
117. Yoneyama M, Fujita T. 2007. Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 282:15315-15318. (Pubitemid 47093255)
118. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M, Jr, Akira S, Yonehara S, Kato A, Fujita T. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851-2858. (Pubitemid 41170502)
119. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737. (Pubitemid 39023305)
120. Yuan H, Yoza BK, Lyles DS. 1998. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251:383-392. (Pubitemid 28535907)
121. Zhou S, Kurt-Jones EA, Fitzgerald KA, Wang JP, Cerny AM, Chan M, Finberg RW. 2007. Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J Immunol 178:5173-5181. (Pubitemid 46595301)